LILRB4 and acute myeloid leukemia: The inhibitory receptor ILT3 is a highly sensitive and specific marker for both diagnosis and monitoring of AML with monocytic differentiation; ILT3 as a marker is particularly useful in the differential diagnosis of AML with monocytic differentiation and microgranular acute promyelocytic leukemia, two leukemia subtypes that require different treatment strategies27.